Sphera Funds Management as of March 31, 2020
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 78 positions in its portfolio as reported in the March 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
iShares Russell 2000 Index (IWM) | 12.9 | $103M | 900k | 114.46 | |
Merck & Co (MRK) | 8.4 | $67M | 869k | 76.94 | |
Spdr S&p 500 Etf (SPY) | 6.8 | $54M | 210k | 257.75 | |
Johnson & Johnson (JNJ) | 5.7 | $46M | 349k | 131.13 | |
Bristol Myers Squibb (BMY) | 5.4 | $44M | 780k | 55.74 | |
Sanofi-Aventis SA (SNY) | 5.3 | $42M | 970k | 43.72 | |
SPDR S&P Biotech (XBI) | 4.8 | $39M | 500k | 77.44 | |
Novo Nordisk A/S (NVO) | 4.3 | $35M | 576k | 60.20 | |
AstraZeneca (AZN) | 3.2 | $26M | 570k | 44.66 | |
Sarepta Therapeutics (SRPT) | 3.2 | $25M | 258k | 97.82 | |
Alexion Pharmaceuticals | 2.8 | $22M | 249k | 89.79 | |
Amicus Therapeutics (FOLD) | 2.3 | $19M | 2.0M | 9.24 | |
Pfizer (PFE) | 2.2 | $18M | 550k | 32.64 | |
Microsoft Corporation (MSFT) | 1.9 | $15M | 94k | 157.71 | |
Abbvie (ABBV) | 1.6 | $13M | 165k | 76.19 | |
Novartis (NVS) | 1.4 | $12M | 140k | 82.45 | |
Karyopharm Therapeutics (KPTI) | 1.3 | $11M | 550k | 19.21 | |
Amazon (AMZN) | 1.3 | $10M | 5.3k | 1949.72 | |
Uniqure Nv (QURE) | 1.2 | $9.5M | 201k | 47.45 | |
Concert Pharmaceuticals I equity | 1.1 | $9.0M | 1.0M | 8.84 | |
X4 Pharmaceuticals (XFOR) | 1.1 | $8.7M | 873k | 10.00 | |
Allot Communications (ALLT) | 1.1 | $8.6M | 915k | 9.45 | |
Y Mabs Therapeutics (YMAB) | 1.0 | $8.0M | 307k | 26.10 | |
Consumer Staples Select Sect. SPDR (XLP) | 1.0 | $7.9M | 145k | 54.47 | |
Zymeworks | 0.9 | $7.3M | 207k | 35.47 | |
Axovant Gene The | 0.9 | $7.2M | 2.9M | 2.44 | |
Passage Bio (PASG) | 0.9 | $7.1M | 478k | 14.92 | |
ACADIA Pharmaceuticals (ACAD) | 0.8 | $6.6M | 157k | 42.25 | |
Blueprint Medicines (BPMC) | 0.8 | $6.4M | 110k | 58.48 | |
Arvinas Ord (ARVN) | 0.7 | $5.9M | 146k | 40.30 | |
Adma Biologics (ADMA) | 0.7 | $5.3M | 1.8M | 2.88 | |
salesforce (CRM) | 0.6 | $5.1M | 36k | 143.97 | |
Trillium Therapeutics, Inc. Cmn | 0.6 | $5.1M | 1.3M | 4.04 | |
Audiocodes Ltd Com Stk (AUDC) | 0.6 | $4.9M | 207k | 23.89 | |
Deciphera Pharmaceuticals | 0.6 | $4.9M | 120k | 41.17 | |
Exicure | 0.6 | $4.9M | 3.3M | 1.48 | |
Beam Therapeutics (BEAM) | 0.6 | $4.8M | 265k | 18.00 | |
Rocket Pharmaceuticals (RCKT) | 0.6 | $4.7M | 335k | 13.95 | |
Galera Therapeutics (GRTX) | 0.6 | $4.5M | 476k | 9.50 | |
Neoleukin Therapeutics | 0.6 | $4.5M | 397k | 11.38 | |
Orgenesis (ORGS) | 0.5 | $4.2M | 1.1M | 3.80 | |
Protagonist Therapeutics (PTGX) | 0.5 | $3.7M | 526k | 7.06 | |
Ascendis Pharma A S (ASND) | 0.5 | $3.7M | 33k | 112.61 | |
Teva Pharmaceutical Industries (TEVA) | 0.4 | $3.2M | 357k | 8.98 | |
Proteostasis Therapeutics In | 0.4 | $2.9M | 2.5M | 1.14 | |
Viking Therapeutics (VKTX) | 0.3 | $2.8M | 590k | 4.68 | |
Palo Alto Networks (PANW) | 0.3 | $2.7M | 17k | 163.93 | |
Aldeyra Therapeutics (ALDX) | 0.3 | $2.6M | 1.1M | 2.47 | |
Fiverr Intl Ltd ord (FVRR) | 0.3 | $2.6M | 105k | 25.17 | |
Cassava Sciences (SAVA) | 0.3 | $2.5M | 615k | 4.11 | |
Zafgen | 0.3 | $2.4M | 3.2M | 0.77 | |
Evolus (EOLS) | 0.3 | $2.3M | 550k | 4.15 | |
Arya Sciences Acquisition Co unit 10/04/2023 | 0.3 | $2.3M | 200k | 11.29 | |
Applied Therapeutics (APLT) | 0.3 | $2.2M | 68k | 32.69 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.2 | $1.9M | 346k | 5.49 | |
Neos Therapeutics | 0.2 | $1.9M | 2.5M | 0.75 | |
Kalvista Pharmaceuticals (KALV) | 0.2 | $1.8M | 240k | 7.65 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.2 | $1.7M | 7.0k | 238.00 | |
Immunovant Inc unit 12/18/2024 (IMVTU) | 0.2 | $1.6M | 95k | 16.55 | |
Argenx Se (ARGX) | 0.2 | $1.4M | 10k | 131.71 | |
Global Blood Therapeutics In | 0.2 | $1.3M | 25k | 51.11 | |
Minerva Neurosciences | 0.1 | $1.0M | 168k | 6.02 | |
Leap Therapeutics | 0.1 | $948k | 600k | 1.58 | |
Precision Biosciences Ord | 0.1 | $889k | 147k | 6.03 | |
Aptinyx | 0.1 | $889k | 412k | 2.16 | |
Syndax Pharmaceuticals (SNDX) | 0.1 | $747k | 68k | 10.96 | |
Allena Pharmaceuticals | 0.1 | $643k | 668k | 0.96 | |
Stoke Therapeutics (STOK) | 0.1 | $624k | 27k | 22.90 | |
Nice Ltd convertible security | 0.1 | $445k | 250k | 1.78 | |
Iveric Bio | 0.1 | $425k | 123k | 3.44 | |
Zynerba Pharmaceuticals | 0.0 | $383k | 100k | 3.83 | |
Cyclerion Therapeutics | 0.0 | $331k | 125k | 2.65 | |
Sunesis Pharmaceuticals Inc Ne | 0.0 | $299k | 722k | 0.41 | |
Immunovant (IMVT) | 0.0 | $296k | 19k | 15.55 | |
Rts/bristol-myers Squibb Compa | 0.0 | $190k | 50k | 3.80 | |
Outlook Therapeutics Inc *w exp 02/18/201 | 0.0 | $130k | 130k | 1.00 | |
Milestone Pharmaceuticals (MIST) | 0.0 | $125k | 68k | 1.84 | |
Cellectar Biosciences | 0.0 | $111k | 88k | 1.27 |